Literature DB >> 3653953

Therapy of pseudomonal infections.

A Kumar.   

Abstract

Mesh:

Substances:

Year:  1987        PMID: 3653953     DOI: 10.1007/BF02749041

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


× No keyword cloud information.
  17 in total

1.  Pseudomonas aeruginosa susceptibility in a university hospital: recognition and treatment.

Authors:  J C Rotschafer; L R Shikuma
Journal:  Drug Intell Clin Pharm       Date:  1986 Jul-Aug

2.  Pseudomonas aeruginosa polysaccharide-tetanus toxoid conjugate vaccine: safety and immunogenicity in humans.

Authors:  S J Cryz; J C Sadoff; E Fürer; R Germanier
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

3.  Emergence of resistance to imipenem during therapy for Pseudomonas aeruginosa infections.

Authors:  J P Quinn; E J Dudek; C A DiVincenzo; D A Lucks; S A Lerner
Journal:  J Infect Dis       Date:  1986-08       Impact factor: 5.226

4.  Active and passive immunization strategies for Pseudomonas aeruginosa pneumonia.

Authors:  J E Pennington; G B Pier; J C Sadoff; G J Small
Journal:  Rev Infect Dis       Date:  1986 Jul-Aug

5.  Use of gentamicin in children with cystic fibrosis.

Authors:  B Boxerbaum; S Pittman; C F Doershuk; R C Stern; L W Matthews
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

Review 6.  Pseudomonas aeruginosa: clinical manifestations and management.

Authors:  I M Gould; R Wise
Journal:  Lancet       Date:  1985-11-30       Impact factor: 79.321

7.  Nalidixic acid in children: retrospective matched controlled study for cartilage toxicity.

Authors:  U B Schaad; J Wedgwood-Krucko
Journal:  Infection       Date:  1987 May-Jun       Impact factor: 3.553

Review 8.  Antibiotic use in cystic fibrosis.

Authors:  H W Kelly; C Lovato
Journal:  Drug Intell Clin Pharm       Date:  1984-10

Review 9.  Infection in patients with cystic fibrosis.

Authors:  T T Rubio
Journal:  Am J Med       Date:  1986-07-28       Impact factor: 4.965

10.  Addition of rifampin to carboxypenicillin-aminoglycoside combination for the treatment of Pseudomonas aeruginosa infection: clinical experience with four patients.

Authors:  V L Yu; J J Zuravleff; J E Peacock; D DeHertogh; L Tashjian
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.